Palvella Therapeutics Files Proxy Statement for Annual Meeting

Ticker: PVLA · Form: DEF 14A · Filed: Apr 30, 2025 · CIK: 1583648

Palvella Therapeutics, Inc. DEF 14A Filing Summary
FieldDetail
CompanyPalvella Therapeutics, Inc. (PVLA)
Form TypeDEF 14A
Filed DateApr 30, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, corporate-governance

TL;DR

Palvella (ex-Pieris) proxy filed for 6/10 meeting. Vote your shares!

AI Summary

Palvella Therapeutics, Inc. (formerly Pieris Pharmaceuticals, Inc.) filed a DEF 14A proxy statement on April 30, 2025, for its annual meeting on June 10, 2025. The company, incorporated in Nevada, operates in the pharmaceutical preparations sector and is headquartered in Wayne, PA.

Why It Matters

This filing provides shareholders with essential information regarding the upcoming annual meeting, including voting matters and company governance, which is crucial for informed shareholder participation.

Risk Assessment

Risk Level: low — This is a routine proxy filing for an annual meeting, not indicating any immediate financial distress or significant operational changes.

Key Players & Entities

  • PALVELLA THERAPEUTICS, INC. (company) — Registrant
  • Pieris Pharmaceuticals, Inc. (company) — Former company name
  • 20250430 (date) — Filing date
  • 20250610 (date) — Meeting date

FAQ

What is the purpose of this DEF 14A filing?

The DEF 14A filing is a proxy statement filed by Palvella Therapeutics, Inc. in accordance with Section 14(a) of the Securities Exchange Act of 1934, providing information to shareholders for their annual meeting.

When is the annual meeting of Palvella Therapeutics, Inc. scheduled?

The annual meeting of Palvella Therapeutics, Inc. is scheduled for June 10, 2025.

What was Palvella Therapeutics, Inc. formerly known as?

Palvella Therapeutics, Inc. was formerly known as Pieris Pharmaceuticals, Inc.

What is the business address of Palvella Therapeutics, Inc.?

The business address of Palvella Therapeutics, Inc. is 125 Strafford Ave, Suite 360, Wayne, PA 19087.

In which state was Palvella Therapeutics, Inc. incorporated?

Palvella Therapeutics, Inc. was incorporated in Nevada (NV).

Filing Details

This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 30, 2025 regarding PALVELLA THERAPEUTICS, INC. (PVLA).

View full filing on EDGAR

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.